[CLTX] Celsus Therapeutics Plc


Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization: 109.39 M

Exchange: NASDAQ

The data is delayed by 15 minutes.


Price: 36.01 Change: 0 (0%)
Ext. hours: Change: 0 (0%)

chart CLTX

Refresh chart

Description: Celsus Therapeutics Plc, a development stage company, is engaged in the discovery and development of non-steroidal and synthetic anti-inflammatory drugs. The company?s principal product candidate is MRX-6, a topical cream that is in Phase 2 clinical trials for the treatment of atopic dermatitis. Its product candidates in pre-clinical studies comprise OPT-1 for the treatment of conjunctivitis, post-operative inflammation, and/or dry eye; and CFX-1 to treat cystic fibrosis and other inflammatory diseases. The company was formerly known as Morria Biopharmaceuticals Plc and changed its name to Celsus Therapeutics Plc in June 2013. Celsus Therapeutics Plc is headquartered in London, the United Kingdom.

Fundamental Ratios
Shares Outstanding556 K EPS-0.29 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters Sales Growth - Q/Q P/E-67.84
P/E To EPS Growth P/S P/BV42.16 Price/Cash Per Share
Price/Free Cash Flow ROA-53.67% ROE-89.29% ROI
Current Ratio4.7 Quick Ratio Long Term Debt/Equity Debt Ratio0.35
Gross Margin Operating Margin Net Profit Margin Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities Cash From Investing Activities Cash From Operating Activities-2.2 M Gross Profit
Net Profit-2.32 M Operating Profit-2.34 M Total Assets4.32 M Total Current Assets4.27 M
Total Current Liabilities910 K Total Debt Total Liabilities1.72 M Total Revenue
Technical Data
High 52 week61.7 Low 52 week4.1 Last close36.01 Last change83.02%
RSI69.39 Average true range18.21 Beta0.05 Volume
Simple moving average 20 days55.59% Simple moving average 50 days155.42% Simple moving average 200 days73.99%
Performance Data
Performance Week65.18% Performance Month-8.95% Performance Quart490.33% Performance Half323.65%
Performance Year-38.76% Performance Year-to-date-24.98% Volatility daily15.64% Volatility weekly34.98%
Volatility monthly71.68% Volatility yearly248.32% Relative Volume0% Average Volume96.08 K
New High New Low